Support

We are very grateful to several grant agencies for supporting our projects. Their grants are indispensable to accomplish our research
objectives (the grants are listed in a chronological order):

National Research, Development and Innovation Office “Frontline” – Research Excellence Programme Title: Nanoscale molecular diversity and neuropsychiatric significance of canonical and non-canonical forms of cannabinoid signaling Period: 2019-2023

National Research, Development and Innovation Office Title: Controlling hippocampal GABAergic neurotransmission by the DGL-alpha enzyme Period: 2017-2019

National Programme in Brain Sciences Title: GPR12, a cryptic orphan receptor associated with neuronal plasticity Period: 2017-2021

National Research, Development and Innovation Office Title: The Abhd4 serine hydrolase, an enigmatic member of the endocannabinoid system: molecular, anatomical and functional characterization in the developing neocortex Period: 2016-2020

 

Momentum II. Program of the Hungarian Academy of Sciences Title: Quantitative molecular characterization of synaptic endocannabinoid signaling Period: 2013-2018

 

The Wellcome Trust International Senior Research Fellowship Title: Molecular architecture and physiological role of novel N-acyl-ethanolamines in neurons. Period: 2010-2016.

 

Swiss-Hungarian Cooperation Programme Swiss partner: Institute of Pharmacology and Toxicology, University of Zurich Title: Unraveling the Role of Novel Molecular Signaling Pathways in the Regulation of Pain Period: 2010-2015

 

European Research Council Starting Independent Researcher Grant Title: Understanding the molecular blueprint and functional complexity of the endocannabinoid metabolome in the brain. Period: 2009-2014.

 

EMBO Long-Term Fellowship for Dr. Christopher Henstridge Period: 2010-2012.

 

Norwegian Financial Mechanism and Hungarian Scientific Research Fund Title: Molecular diversity and plasticity of endocannabinoid signaling at cortical synapses Period: 2009-2011.